Activation of CCR5 by Chemokines Involves an Aromatic Cluster between Transmembrane Helices 2 and 3*
暂无分享,去创建一个
Shoshana J. Wodak | Marc Parmentier | Leonardo Pardo | Xavier Deupi | Mireia Olivella | S. Wodak | L. Pardo | M. Parmentier | J. Springael | X. Deupí | C. Blanpain | C. Govaerts | A. Bondue | E. Le Poul | Antoine Bondue | Cédric Govaerts | Cédric Blanpain | Emmanuel Le Poul | M. Olivella | Jean-Yves Springael
[1] H. Schägger,et al. Tricine-sodium dodecyl sulfate-polyacrylamide gel electrophoresis for the separation of proteins in the range from 1 to 100 kDa. , 1987, Analytical biochemistry.
[2] J. Ballesteros,et al. [19] Integrated methods for the construction of three-dimensional models and computational probing of structure-function relations in G protein-coupled receptors , 1995 .
[3] T. Steiner,et al. Hydrogen bonds with pi-acceptors in proteins: frequencies and role in stabilizing local 3D structures. , 2001, Journal of molecular biology.
[4] H. Guy,et al. Epitope Mapping of CCR5 Reveals Multiple Conformational States and Distinct but Overlapping Structures Involved in Chemokine and Coreceptor Function* , 1999, The Journal of Biological Chemistry.
[5] D. Missé,et al. HIV-1 glycoprotein 120 induces the MMP-9 cytopathogenic factor production that is abolished by inhibition of the p38 mitogen-activated protein kinase signaling pathway. , 2001, Blood.
[6] M. Baggiolini. Chemokines and leukocyte traffic , 1998, Nature.
[7] D. Larhammar,et al. Mutagenesis of the human 5-HT1B receptor: differences from the closely related 5-HT1A receptor and the role of residue F331 in signal transduction. , 1998, Journal of receptor and signal transduction research.
[8] Xi-Ping Huang,et al. Roles of threonine 192 and asparagine 382 in agonist and antagonist interactions with M1 muscarinic receptors , 1999, British journal of pharmacology.
[9] Shoshana J. Wodak,et al. The TXP Motif in the Second Transmembrane Helix of CCR5 , 2001, The Journal of Biological Chemistry.
[10] S. Rees,et al. A bioluminescent assay for agonist activity at potentially any G-protein-coupled receptor. , 1997, Analytical biochemistry.
[11] C. Strader,et al. The role of histidine 265 in antagonist binding to the neurokinin-1 receptor. , 1994, The Journal of biological chemistry.
[12] N. Taylor,et al. Macrophage inflammatory protein-1β induces migration and activation of human thymocytes , 1998 .
[13] Roger E Bumgarner,et al. Benzene Forms Hydrogen Bonds with Water , 1992, Science.
[14] E. Meng,et al. Receptor activation: what does the rhodopsin structure tell us? , 2001, Trends in pharmacological sciences.
[15] Lawrence M. Lifshitz,et al. Close contacts with the endoplasmic reticulum as determinants of mitochondrial Ca2+ responses. , 1998, Science.
[16] Leonardo Pardo,et al. Influence of the environment in the conformation of alpha-helices studied by protein database search and molecular dynamics simulations. , 2002, Biophysical journal.
[17] H. Akil,et al. Hydrophobic Residues of the D2 Dopamine Receptor Are Important for Binding and Signal Transduction , 1995, Journal of neurochemistry.
[18] Z. Vogel,et al. Functional Role of Tryptophan Residues in the Fourth Transmembrane Domainof the CB2 Cannabinoid Receptor , 2000, Journal of neurochemistry.
[19] J. Farber,et al. Chemokine receptors as HIV-1 coreceptors: roles in viral entry, tropism, and disease. , 1999, Annual review of immunology.
[20] Marc Parmentier,et al. Multiple active states and oligomerization of CCR5 revealed by functional properties of monoclonal antibodies. , 2002, Molecular biology of the cell.
[21] T. Schwartz,et al. Conserved HisVI‐17 of the NK‐1 receptor is involved in binding of non‐peptide antagonists but not substance P , 1993, FEBS letters.
[22] L. Kelley,et al. An automated approach for clustering an ensemble of NMR-derived protein structures into conformationally related subfamilies. , 1996, Protein engineering.
[23] J. Ballesteros,et al. A cluster of aromatic residues in the sixth membrane-spanning segment of the dopamine D2 receptor is accessible in the binding-site crevice. , 1998, Biochemistry.
[24] B. Roth,et al. Identification of conserved aromatic residues essential for agonist binding and second messenger production at 5-hydroxytryptamine2A receptors. , 1997, Molecular pharmacology.
[25] D. Farrens,et al. Conformational Changes in Rhodopsin , 1999, The Journal of Biological Chemistry.
[26] S. Cooper,et al. Role of the His273 located in the sixth transmembrane domain of the angiotensin II receptor subtype AT2 in ligand-receptor interaction. , 1999, Biochemical and biophysical research communications.
[27] J. Ballesteros,et al. Dopamine D4/D2 receptor selectivity is determined by A divergent aromatic microdomain contained within the second, third, and seventh membrane-spanning segments. , 1999, Molecular pharmacology.
[28] H. Khorana,et al. Requirement of Rigid-Body Motion of Transmembrane Helices for Light Activation of Rhodopsin , 1996, Science.
[29] M. Scheinin,et al. Chloroethylclonidine and 2-Aminoethyl Methanethiosulfonate Recognize Two Different Conformations of the Human α2A-Adrenergic Receptor* , 1999, The Journal of Biological Chemistry.
[30] M. Grossmann,et al. G Protein-coupled Receptors , 1998, The Journal of Biological Chemistry.
[31] Marc Parmentier,et al. The Second Extracellular Loop of CCR5 Is the Major Determinant of Ligand Specificity* , 1997, The Journal of Biological Chemistry.
[32] C. Strader,et al. Amino–aromatic interaction between histidine 197 of the neurokinin-1 receptor and CP 96345 , 1993, Nature.
[33] R. Doms,et al. CCR5 binds multiple CC-chemokines: MCP-3 acts as a natural antagonist. , 1999 .
[34] J. Wess,et al. Site-directed Mutagenesis Identifies Residues Involved in Ligand Recognition in the Human A2a Adenosine Receptor (*) , 1995, The Journal of Biological Chemistry.
[35] J. Ballesteros,et al. The role of a conserved proline residue in mediating conformational changes associated with voltage gating of Cx32 gap junctions. , 1999, Biophysical journal.
[36] T. Darden,et al. Particle mesh Ewald: An N⋅log(N) method for Ewald sums in large systems , 1993 .
[37] R. Doms,et al. Palmitoylation of CCR5 Is Critical for Receptor Trafficking and Efficient Activation of Intracellular Signaling Pathways* , 2001, The Journal of Biological Chemistry.
[38] P. Kollman,et al. A Second Generation Force Field for the Simulation of Proteins, Nucleic Acids, and Organic Molecules , 1995 .
[39] J. Wess,et al. Site‐directed mutagenesis of the m3 muscarinic receptor: identification of a series of threonine and tyrosine residues involved in agonist but not antagonist binding. , 1991, The EMBO journal.
[40] G A Petsko,et al. Aromatic-aromatic interaction: a mechanism of protein structure stabilization. , 1985, Science.
[41] R. Osman,et al. A hydrophobic cluster between transmembrane helices 5 and 6 constrains the thyrotropin-releasing hormone receptor in an inactive conformation. , 1998, Molecular pharmacology.
[42] K. Palczewski,et al. Crystal Structure of Rhodopsin: A G‐Protein‐Coupled Receptor , 2002, Chembiochem : a European journal of chemical biology.
[43] B. Rollins,et al. Chemokines and disease , 2001, Nature Immunology.
[44] G Vassart,et al. Extracellular Cysteines of CCR5 Are Required for Chemokine Binding, but Dispensable for HIV-1 Coreceptor Activity* , 1999, The Journal of Biological Chemistry.
[45] Leonardo Pardo,et al. Serine and Threonine Residues Bend α-Helices in the χ1 = g− Conformation , 2000 .
[46] Kazumasa Honda,et al. The Magnitude of the CH/π Interaction between Benzene and Some Model Hydrocarbons , 2000 .
[47] H Weinstein,et al. Agonists induce conformational changes in transmembrane domains III and VI of the β2 adrenoceptor , 1997, The EMBO journal.
[48] K D Ridge,et al. Light-induced exposure of the cytoplasmic end of transmembrane helix seven in rhodopsin. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[49] Roland L. Dunbrack,et al. Prediction of protein side-chain rotamers from a backbone-dependent rotamer library: a new homology modeling tool. , 1997, Journal of molecular biology.
[50] T. Bártfai,et al. Delineation of the peptide binding site of the human galanin receptor. , 1996, The EMBO journal.
[51] L. Pardo,et al. Design, synthesis and pharmacological evaluation of 5-hydroxytryptamine(1a) receptor ligands to explore the three-dimensional structure of the receptor. , 2002, Molecular pharmacology.
[52] 宁北芳,et al. 疟原虫var基因转换速率变化导致抗原变异[英]/Paul H, Robert P, Christodoulou Z, et al//Proc Natl Acad Sci U S A , 2005 .